期刊文献+

SOX7基因在乳腺癌中的研究进展 被引量:3

Research advances of SOX7 gene in breast cancer
原文传递
导出
摘要 在乳腺癌等一些人类肿瘤的研究中发现,SOX7基因极有可能是一个抑癌基因。SOX7基因抑癌作用的机制可能是通过调节Wnt/β-catenin信号通路介导的转录过程来完成的,而异常的Wnt/β-catenin信号通路则有可能通过调控其下游的靶向基因Cyclin D1等来发挥其作用,使细胞的异常增生活动无法进行下去,从而发挥其肿瘤抑制的功能。本文就目前乳腺癌中SOX7基因的作用及其与之密切相关的β-cate—nin、Cyclin D1基因的研究现状作一综述。 Study found that in some human tumors such as breast cancer, SOX7 gene is highly likely to be a tumor suppressor gene. The tumor suppressor role of SOX7 may be accomplished by regulating the Wnt/β-catenin signaling pathway mediated the transcription process, and the abnormal Wnt/β-catenin signaling pathway is likely to play its role through the regulation of its downstream target gene Cyclin D1, etc, so that the abnormal cell proliferation activity is unable to carry on, and thus plays the function of tumor suppressor. This review will summarize the research progress of the role of SOX7 gene and its closely related β-catenin, Cyclin D1 gene in breast cancer.
出处 《国际外科学杂志》 2012年第10期695-698,共4页 International Journal of Surgery
关键词 乳腺肿瘤 基因 SOX7 β—catenin CYCLIN D1 Breast neoplasms Genes SOX7 β-catenin Cyclin D1
  • 相关文献

参考文献6

二级参考文献46

  • 1杨剑锋,陈森林,刘志红,张芸.乳腺癌组织中E-cadherin、β-catenin及cyclin D1表达的相关性研究[J].癌症,2004,23(7):799-802. 被引量:23
  • 2丁克峰,邓甬川.乳腺癌改良根治术后创面处理的改进分析[J].浙江大学学报(医学版),2004,33(5):456-458. 被引量:14
  • 3Morin PJ.Beta-catenin signaling and cancer [J].Bioessays,1999,21(12):1021-1030.
  • 4Resnik E.Beta catenin-one player,tow games [J].Nat Genet,1997,16(1):9-11.
  • 5Gonzalez MA,Pinder SE,Wencyk PM,et al.An immunohistochemical examination of the expression of E-cadherin,α and β/γ-catenins,and α 2 and β 1 integrins in invasive breast cancer [J].J Pathol,1999,187(5):523-529.
  • 6Maruyama K,Ochiai A,Akimoto S,et al.Cytoplasmic beta-catenin accumulation as a predictor of hematogenous metastasis in human colorectal cancer [J].Oncology,2000,59(4):302-309.
  • 7Ishikawa T,Furihata M,Ohtsuki Y,et al.Cyclin D1 overexpression related to retinoblastoma protein expression as a prognostic marker in human oesophageal squamous cell carcinoma [J].Br J Cancer,1998,77(1):92-97.
  • 8Gillett C,Fantl V,Smith R,et al.Amplification and overexpression of Cyclin D1 in breast cancer detected by immunohistochemical staining [J].Cancer Res,1994,54(7):1812-1817.
  • 9Fantl V,Smith R,Brookes S,et al.Chromosome 11q13 abnormalities in human breast cancer [J].Cancer Surv,1993,18:77-94.
  • 10St Croix B,Sheehanc C,Rak JW,et al.E-cadherin-dependent growth suppression is mediated by the Cyclin-dependent kinase inhibitor p27(KIP1) [J].J Cell Biol,1998,142(2):557-571.

共引文献79

同被引文献76

  • 1Makino S. The role of tumor stem cell in regrowth of the tumor fol- lowing drastic applications [ J]. Acta Unio Int Contra Cancrum, 1959, 15 (Suppl 1): 196-198.
  • 2Clarke RB, Anderson E, Howell A, et al. Regulation of human breast epithelial stem cells [ J ]. Cell Prolif, 2003, 36 (Suppl 1 ) : 45-58.
  • 3Lodie TA, Blickarz CE, Devarakonda T, et al. Systematic analysis of reportedly distinct populations of multipotent bone marrow de- rived stem cell reveals a lack of distinction[ J]. Tissue Eng, 2002, 8(5) : 739-751.
  • 4AL-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells[ J]. Proc Nail Acad Sci U S A, 2003, 100 (7) : 3983-3988.
  • 5Kondo T, Setoguchi T, Taga T. Persistence of a small subpupula- tion of cancer stem-like cells in the C6 glioma cell line[ J]. Proc Natl Acad Sci U S A, 2004, 101 (3) : 781-786.
  • 6Kakarala M, Wicha MS. Implications of the cancer stem cell hy- pothesis for breast cancer preven tion and therapy[ J]. J Clin On- col, 2008, 26 (17) : 2813-2820.
  • 7Ricardo S, Vieira AF, Gerhard R, et al. Breast cancer stem cell markers CD44, CD24 and ALDHI: expression distribution within in- trinsic molecular subtype [ J ]. J Clin Pathol, 2011,64 (11) : 937-946.
  • 8Tanei T, Morimoto K, Shimazu K, et al. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chem- otherapy for breast cancers[ J]. Clin Cancer Res, 2009, 15 (12) : 4234-4241.
  • 9Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDHI is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome [ J ]. Cell Stem Cell, 2007, 1 (5) : 555-567.
  • 10Madjd Z, Ramezani B, Molanae S, et al. High expression of stem cell marker ALDHI is associated with reduced BRCA1 in invasive breast carcinomas [ J ]. Asian Pac J Cancer Prey, 2012, 13 ( 6 ) : 2973 -2978.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部